This one-hour webinar will cover key changes in the management of HIV pre-exposure prophylaxis (PrEP) for the United States, following the issuance of the most recent CDC/USPHS PrEP Guideline update in December 2021. Participants will learn about the evidence base behind the changes and where to find resources to help support the implementation of updated recommendations. The speaker, Dr. Christopher Hurt from the UNC School of Medicine, has been working to help providers implement PrEP in North Carolina since 2014 and is an expert on PrEP service delivery.
PrEP in 2022: What's New in the Guidelines?
By: Christopher Hurt, MD, FIDSA
Friday, February 18th
12:00pm - 1:00pm EST
Register Now
Objectives
- Identify key updates in the 2021 CDC/USPHS PrEP Guidelines for the US.
- Distinguish among oral and injectable options approved for HIV pre-exposure prophylaxis (PrEP) in the US.
- Explain the rationale for combining antigen/antibody and RNA testing to screen for HIV among patients actively taking PrEP.
- Describe how federal regulatory changes in PrEP coverage impact patients who have insurance.
CME Information
Accreditation Statement
The School of Medicine of the University of North Carolina at Chapel Hill is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Statement
The School of Medicine of the University of North Carolina at Chapel Hill designates this live internet activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure statement
This activity has been planned and implemented under the sole supervision of the Course Director, Christopher Hurt, MD, FIDSA in association with the UNC Office of Continuing Professional Development (CPD). The course director and CPD staff have no relevant financial relationships with ineligible companies as defined by the ACCME.